An NCI-designated Comprehensive Cancer Center
Roger Satterthwaite

Roger W. Satterthwaite, M.D., M.P.H.

Urologic Surgeon
Clinical Expertise
Research Focus
  • Urologic Oncology
Assistant Clinical Professor, Division of Urology and Urologic Oncology, Department of Surgery
Referring Physicians/Colleagues: 626-218-9505
Email: [email protected]
Other Languages Spoken
  • Spanish

Clinical Teams

  • Genitourinary Cancers
  • Urology and Urologic Cancers
Roger Satterthwaite, M.D., M.P.H., started his medical career as a 19-year-old medic in the U.S. Army. After stints as a paratrooper and in the mountain infantry, he completed his Bachelor of Arts degree in history at Dartmouth College with an emphasis in Latin American studies and lettered on the nationally ranked Dartmouth cross country team. Between 1987 and 1991, Dr. Satterthwaite then completed both a master's degree at the Mailman School of Public Health and his medical degree at the College of Physicians and Surgeons at top-ranked Columbia University in New York City. He followed with an equally rigorous urology residency at the University of Southern California/Norris Cancer Center, where he published in the transplantation literature.
From 1997 to 2003, Dr. Satterthwaite served in the U.S. Air Force as chief of urology at MacDill Air Force Base and Royal Air Force Base Lakenheath, in addition to directing the Surgical Subspecialty Flight at Travis Air Force Base. After being selected for lieutenant colonel, Dr. Satterthwaite departed the Air Force for two years of private practice in Hawaii. He then joined City of Hope in 2005, first as a fellow in urologic oncology and robotic surgery, followed by a staff appointment in the City of Hope Medical Group. Dr. Satterthwaite is a highly experienced robotic surgeon who has also performed thousands of endoscopic procedures. Dr. Satterthwaite also helped found and currently directs the full service community urology practice for City of Hope which currently employs 13 full time urologists who collectively see thousands of patients, perform about 200 robotic surgeries and many more general urology procedures per year and work out of clinics in Lancaster, Santa Clarita, Mission Hills, Pasadena, Arcadia, Glendora, West Covina and Upland.
Dr. Satterthwaite has lived in El Salvador, Costa Rica and England, and travelled extensively through Asia and studied abroad in Austria and Honduras. In addition, he has worked on Air Force bases in Germany and Turkey. He is a member of the Los Angeles County, California and American Medical Associations as well as the American Urology Association. He has served on the Board of the City of Hope Medical Group and served his specialty in the American Medical Association House of Delegates, as well as a lobbyist on Capitol Hill. Dr. Satterthwaite proudly supports Doctors Without Borders, Physicians for Human Rights and Amnesty International. He speaks fluent Spanish, high school German and French, basic Mandarin and, from 15 years of taekwondo, can count to 20 in Korean.


630 S. Raymond Ave., Suite 220

Pasadena, CA 91105

Satterthwaite R et al. Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine. Transplantation. 1998 Feb 15; 65(3): 446-9; Satterthwaite R et al. Risks of transplanting kidneys from Hepatitis B surface antigen-negative, hepatitis B core antibody-positive donors. Transplantation. 1997 Aug 15; 64(3): 432-5; Satterthwaite R et al. Outcome of en-bloc and single kidney transplants from very young cadaveric donors. Transplantation. 1997 May 27; 63(10): 1405-10
In The News